Requests that the FDA file an application for an abbreviated new animal drug application (ANADA) for a generic oral suspension for Trilostane that differs from the pioneer product, VETORYL CAPSULES, sponsored by Dechra Veterinary Products. under NADA 141-291 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2026-P-4061

Requests that the FDA file an application for an abbreviated new animal drug application (ANADA) for a generic oral suspension for Trilostane that differs from the pioneer product, VETORYL CAPSULES, sponsored by Dechra Veterinary Products. under NADA 141-291

Documents

Comments

Key Dates

Comment Period OpensApr 17, 2026

Documents

Type	Title	Posted	Comments	Status
Supporting Material	Attachment 1	Apr 17, 2026	--

Keywords

CVM

Suitability Petition

Felix Pharmaceuticals Pvt Ltd

file an application

for an abbreviated new animal drug application

for a generic

oral suspension for Trilostane that differs

from the pioneer product

Data from Regulations.gov